Catalyst
Slingshot members are tracking this event:
Vanda Pharmaceuticals (VNDA) to submit NDA for Tradipitant in Pruritus to FDA in 2020
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VNDA | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 25, 2020
Occurred Source:
https://www.prnewswire.com/news-releases/vanda-reports-results-from-the-epione-study-of-tradipitant-in-the-treatment-of-pruritus-in-atopic-dermatitis-301011169.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pruritus, Fda Review, Tradipitant
